Awareness and attitudes concerning BRCA gene testing

Annals of Surgical Oncology

Volumn 5, Issue 7, 1998, Pages 607-612

  Mogilner, Avigyail ^a   Otten, Marc ^a   Cunningham, John D ^a,b   Brower, Steven T ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b Box 1259 ^*  (United States)

Author keywords

BRCA 1; BRCA 2; Breast cancer; Genetic counseling

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER GENETICS; CANCER SUSCEPTIBILITY; CAUCASIAN; EDUCATION; GENETIC COUNSELING; GENETIC EPIDEMIOLOGY; GENETIC SUSCEPTIBILITY; HUMAN; JEW; MAJOR CLINICAL STUDY; NEGRO; RACE DIFFERENCE;

EID: 0031753049     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02303830     Document Type: Article

References (33)

1. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1996. CA Cancer J Clin 1996;43:5-27.
2. Claus EB, Risch N, Thompson WD. Autosomal dominant inheritance of early onset breast cancer: implications for risk prediction. Cancer 1994;73:643-51.
3. deWit AC, Meijers-Heijober EJ, Tibben A, et al. Effect of a Dutch family on predictive DNA-testing for hereditary breast and ovarian cancer. Lancet 1994;344:197.
4. Ford D, Easton DF, Peto J. Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. Am J Hum Genet 1995;57:1457-62.
5. Hulka BS, Stark AT. Breast cancer: cause and prevention. Lancet 1995;346:883-7.
6. Hall JM, Friedman L, Guenther C, et al. Closing in on a breast cancer gene on chromosome 17q. Am J Hum Genet 1992;50:1235-42.
7. Friedman LS, Ostermeyer EA, Szabo CI, et al. Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families. Nat Genet 1994;8:399-404.
8. Miki Y, Swenson J, Shattuck-Eidens D, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994;266:66-71.
9. Wooster R, Bignell G, Lancaster J, et al. Identification of the breast cancer susceptibility gene BRCA2. Nature 1995;378:789-92.
10. Tavtigian SV, Simard J, Rommens J, et al. The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nat Genet 1996;12:333-7.
11. Wooster R, Neuhausen SL, Mangion J, et al. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 1994;265:2088-90,
12. Easton DF, Bishop DT, Ford D, Crockford GP. Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. Am J Hum Genet 1993;52:678-701.
13. Ford D, Easton DF, Bishop PT, Navod SA, Boldgar DE. Risks of cancer in BRCA1 mutation carriers: Breast Cancer Linkage Consortium. Lancet 1994;343:692-5.
14. Shattuck-Eidens D, McClure M, Simard J, et al. A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene. JAMA 1995;273:535-41.
15. Ford D, Easton DF. The genetics of breast and ovarian cancer. Br J Cancer 1995;72:805-12.
16. Szabo CI, King MC. Inherited breast and ovarian cancer. Hum Mol Genet 1995;4:1811-17.
17. Lerman C, Seay J, Bedsham A, Andrain J. Interest in genetic testing among first-degree relatives of breast cancer patients. Am J Med Genet 1995;57:385-92.
18. Friedman LS, Szabo CI, Ostermeyer EA, et al. Novel inherited mutations and variable expressivity of BRCA1 alleles, including the founder mutation 185delAG in Ashkenazi Jewish families. Am J Hum Genet 1995;57:1284-97.
19. Struewing JP, Abeliovieh D, Peretz T, et al. The carrier frequency of the BRCA1 185dclAG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Nat Genet 1995;11:198-200.
20. Kash KM, Holland JC, Osborne MP, Miller DC. Psychologic counseling strategies for women at risk of breast cancer. J Natl Cancer Inst 1995;17:73-7.
21. Kash KM, Holland JC, Halper MS, Miller DG. Psychological distress and surveillance behaviors of women with a family history of breast cancer. J Natl Cancer Inst 1992;84:24-30.
22. Lerman C, Kash K, Stefanek M. Younger women at increased risk of breast cancer: perceived risk, psychological well being, and surveillance behavior. J Natl Cancer Inst Monogr 1994;16:171-6.
23. Lerman C, Croyle K. Psychological issues in genetic testing for breast cancer susceptibility. Arch Intern Med 1994;154:609-16.
24. Lerman C, Daly M, Masny A, Bedshem A. Attitudes about genetic testing for breast-ovarian cancer susceptibility. J Clin Oncol 1994;12:843-50.
25. Lerman C, Rimer BK. Psychosocial impact of cancer screening. Oncology 1993;7:67-72.
26. Geller G, Bernhardt BA, Helzlsouer K, Holtzman NA, Stefana KM, Wilcox PM. Informed consent and BRCA1 testing. Nat Genet 1995;11:364.
27. Hudson KL, Rothenberg KH, Andrews LB, Kahn MJ, Collins FS. Genetic discrimination and health insurance: an urgent need for reform. Science 1995;270:3491-3.
28. Genetic Testing and Insurance: Ad Hoc Committee on Genetic Testing/Insurance Issues. Am J Hum Genet 1995;56:327-31.
29. Burke W, Daly M, Garber J, Botkin J, Kahn MJ, Lynch P. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II BRCA1 and BRCA2. JAMA 1997;277:997-1003.
30. Hoskins KF, Stopfer JE, Calzone KA, et al. Assessment and counseling for women with a family history of breast cancer: a guide for clinicians. JAMA 1995;273:577-85.
31. Mies C. Recurrent secretory carcinoma in residual mammary tissue after mastectomy. Am J Surg Pathol 1993;17:715-21.
32. Wapnir IL, Rabinowitz B, Greco RS. A reappraisal of prophylactic mastectomy. Surg Gynecol Obstet 1990;171:171-84.
33. Eldar S, Meguid MM, Beatty JD. Cancer of the breast after prophylactic mastectomy. Am J Surg 1984;148:692-3.